Drug interactions for the following drug(s)
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> Sertraline 50 MG Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Sertraline.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> Simvastatin 40 MG Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Simvastatin.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> Simvastatin 40 MG Oral Tablet
The metabolism of Simvastatin can be decreased when combined with Levothyroxine.
Applies to: Sertraline 50 MG Oral Tablet <> Simvastatin 40 MG Oral Tablet
The metabolism of Simvastatin can be decreased when combined with Sertraline.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> levothyroxine sodium 50 MCG Oral Tablet
Omeprazole can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: Furosemide 40 MG Oral Tablet <> cyanocobalamin 25 MCG / folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG Oral Tablet
Cyanocobalamin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Applies to: Folic Acid 1 MG Oral Tablet <> Furosemide 40 MG Oral Tablet
Furosemide may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: cyanocobalamin 25 MCG / folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG Oral Tablet <> Furosemide 40 MG Oral Tablet
Furosemide may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: Folic Acid 1 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Capsule
Omeprazole may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
Ferrous sulfate anhydrous can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> Sertraline 50 MG Oral Tablet
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Sertraline.
Omeprazole may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
The absorption of Ferrous sulfate anhydrous can be decreased when combined with Omeprazole.
Applies to: Furosemide 40 MG Oral Tablet <> levothyroxine sodium 50 MCG Oral Tablet
The protein binding of Furosemide can be decreased when combined with Levothyroxine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> Sertraline 50 MG Oral Tablet
Drug1 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Omeprazole and Sertraline.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> Simvastatin 40 MG Oral Tablet
Drug1 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 198211, name = simvastatin 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to simvastatin and interaction asserted in DrugBank between Omeprazole and Simvastatin.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> Simvastatin 40 MG Oral Tablet
Drug1 (rxcui = 966221, name = levothyroxine sodium 0.05 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198211, name = simvastatin 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to simvastatin and interaction asserted in DrugBank between Levothyroxine and Simvastatin.
Applies to: Sertraline 50 MG Oral Tablet <> Simvastatin 40 MG Oral Tablet
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198211, name = simvastatin 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to sertraline, Drug2 is resolved to simvastatin and interaction asserted in DrugBank between Sertraline and Simvastatin.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> levothyroxine sodium 50 MCG Oral Tablet
Drug1 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 966221, name = levothyroxine sodium 0.05 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Omeprazole and Levothyroxine.
Applies to: Furosemide 40 MG Oral Tablet <> cyanocobalamin 25 MCG / folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG Oral Tablet
Drug1 (rxcui = 313988, name = furosemide 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 978676, name = folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG / vitamin B12 0.025 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to vitamin B12 and interaction asserted in DrugBank between Furosemide and Cyanocobalamin.
Applies to: Folic Acid 1 MG Oral Tablet <> Furosemide 40 MG Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313988, name = furosemide 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Folic acid and Furosemide.
Applies to: cyanocobalamin 25 MCG / folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG Oral Tablet <> Furosemide 40 MG Oral Tablet
Drug1 (rxcui = 978676, name = folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG / vitamin B12 0.025 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 313988, name = furosemide 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to furosemide and interaction asserted in DrugBank between Folic acid and Furosemide.
Applies to: Folic Acid 1 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Capsule
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Folic acid and Omeprazole.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
Drug1 (rxcui = 966221, name = levothyroxine sodium 0.05 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310325, name = ferrous sulfate 325 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to ferrous sulfate and interaction asserted in DrugBank between Levothyroxine and Ferrous sulfate anhydrous.
Applies to: levothyroxine sodium 50 MCG Oral Tablet <> Sertraline 50 MG Oral Tablet
Drug1 (rxcui = 966221, name = levothyroxine sodium 0.05 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Levothyroxine and Sertraline.
Drug1 (rxcui = 978676, name = folic acid 1 MG / heme iron polypeptide 6 MG / polysaccharide iron complex 22 MG / vitamin B12 0.025 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Folic acid and Omeprazole.
Applies to: Omeprazole 20 MG Delayed Release Oral Capsule <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
Drug1 (rxcui = 198051, name = omeprazole 20 MG Delayed Release Oral Capsule, tty = SCD). Drug2 (rxcui = 310325, name = ferrous sulfate 325 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to ferrous sulfate and interaction asserted in DrugBank between Omeprazole and Ferrous sulfate anhydrous.
Applies to: Furosemide 40 MG Oral Tablet <> levothyroxine sodium 50 MCG Oral Tablet
Drug1 (rxcui = 313988, name = furosemide 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966221, name = levothyroxine sodium 0.05 MG Oral Tablet, tty = SCD). Drug1 is resolved to furosemide, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Furosemide and Levothyroxine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.